Australia markets open in 2 hours 33 minutes

Sonnet BioTherapeutics Holdings, Inc. (SONN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.6700-0.1400 (-7.73%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
129.176
147.805
349.943
483.626
0
Operating expenses
Research development
8,713
11,815
21,444
16,635
9,878
Selling general and administrative
5,875
7,126
8,575
8,937
7,534
Total operating expenses
14,588
18,940
30,019
25,571
17,411
Operating income or loss
-14,459
-18,793
-29,669
-25,087
-17,411
Total other income/expenses net
0.033
-40.077
-52.482
103.46
-6,875
Income before tax
-14,459
-18,833
-29,722
-24,984
-24,265
Income from continuing operations
-14,459
-18,833
-29,722
-24,984
-24,265
Net income
-14,459
-18,833
-29,722
-24,984
-24,265
Net income available to common shareholders
-14,459
-18,833
-29,722
-24,984
-65,604
Basic EPS
-18.14
-18.14
-150.52
-313.50
-2.14k
Diluted EPS
-18.14
-18.14
-150.52
-313.50
-2.14k
Basic average shares
1,038
1,038
197.462
79.699
30.585
Diluted average shares
1,038
1,038
197.462
79.699
30.585